October 28-30, 2026 | Coronado Island Marriott Resort and Spa 2000 2nd St, Coronado, CA 92118
The Alliance for mRNA Medicines (AMM) brings together senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients. The annual meeting, AMM ASCENT (Advancements in mRNA Science, Commercialization, Education, and Novel Technologies), features one-on-one partnering opportunities for companies and investors, dedicated networking, keynotes and fireside chats featuring KOLs and industry visionaries, as well as engaging plenary and panel discussions among biotech, pharma, and academic leaders. Our meeting this year is in collaboration with the Society for RNA Therapeutics.
Call for Abstracts
As part of this collaboration, AMM and SRT are accepting submissions for oral or poster presentations for two scientific sessions:
Submit your abstract by August 1 through this form.
The Alliance for mRNA Medicines (AMM) is dedicated to advancing and advocating for an RNA platform approach to medicine, including protein replacements, gene editing and cell engineering strategies, immunotherapies and vaccines to treat cancer, rare disease, autoimmunity and other chronic and infectious illnesses for the benefit of patients, public health, and society.
We advance this mission by shaping policy, accelerating regulatory science, expanding access, and enabling manufacturing — while convening the scientists, innovators, and industry leaders who are turning RNA’s promise into reality. Our goal is simple: ensure that transformative RNA medicines reach every patient who needs them.
